• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清钙蛋白颗粒与磷酸盐比值作为新发血液透析患者心血管事件的预测指标

Serum calciprotein particle-to-phosphate ratio as a predictor of cardiovascular events in incident hemodialysis patients.

作者信息

Akiyama Tomoki, Iwazu Yoshitaka, Usui Joichi, Ebihara Itaru, Ishizu Takashi, Kobayashi Masaki, Maeda Yoshitaka, Kobayashi Hiroaki, Yamagata Kunihiro, Kuro-O Makoto

机构信息

Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Division of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.

出版信息

Ther Apher Dial. 2025 Apr;29(2):178-188. doi: 10.1111/1744-9987.14203. Epub 2024 Sep 4.

DOI:10.1111/1744-9987.14203
PMID:39229751
Abstract

INTRODUCTION

Recent studies have identified increased blood calciprotein particle (CPP) levels as risk factors for vascular calcification and cardiovascular events in patients undergoing maintenance hemodialysis. Although positively correlated with serum phosphate levels, serum CPP levels vary considerably among patients with similar serum phosphate levels. We investigated the capacity of the ratio of serum CPP levels to serum phosphate levels (CPP/Pi ratio) to predict cardiovascular events in incident hemodialysis patients compared to the serum calcification propensity test (T).

METHODS AND RESULTS

The association between the CPP/Pi ratio and major adverse cardiac and cerebrovascular events (MACCE) was investigated in 174 incident hemodialysis patients. Multivariate analysis revealed that the CPP/Pi ratio was independently associated with MACCE [hazard ratio 1.60, 95% confidence interval (1.15-2.23), p = 0.006] but serum T levels were not.

CONCLUSIONS

The CPP/Pi ratio is a useful, novel biomarker for predicting the risk of cardiovascular events in patients undergoing incident hemodialysis.

摘要

引言

最近的研究已确定血液中钙蛋白颗粒(CPP)水平升高是维持性血液透析患者血管钙化和心血管事件的危险因素。尽管血清CPP水平与血清磷酸盐水平呈正相关,但在血清磷酸盐水平相似的患者中,血清CPP水平差异很大。我们研究了血清CPP水平与血清磷酸盐水平之比(CPP/ Pi比值)相较于血清钙化倾向试验(T)预测新发血液透析患者心血管事件的能力。

方法与结果

在174例新发血液透析患者中研究了CPP/ Pi比值与主要不良心脑血管事件(MACCE)之间的关联。多变量分析显示,CPP/ Pi比值与MACCE独立相关[风险比1.60,95%置信区间(1.15 - 2.23),p = 0.006],而血清T水平则不然。

结论

CPP/ Pi比值是预测新发血液透析患者心血管事件风险的一种有用的新型生物标志物。

相似文献

1
Serum calciprotein particle-to-phosphate ratio as a predictor of cardiovascular events in incident hemodialysis patients.血清钙蛋白颗粒与磷酸盐比值作为新发血液透析患者心血管事件的预测指标
Ther Apher Dial. 2025 Apr;29(2):178-188. doi: 10.1111/1744-9987.14203. Epub 2024 Sep 4.
2
Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.血清钙磷复合物颗粒大小和转化时间与新发生血液透析患者动脉钙化、动脉僵硬度和死亡率的相关性。
Am J Kidney Dis. 2021 Mar;77(3):346-354. doi: 10.1053/j.ajkd.2020.05.031. Epub 2020 Aug 13.
3
Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.在 EVOLVE 试验中接受血液透析的患者的血液钙化倾向、心血管事件和生存。
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):315-322. doi: 10.2215/CJN.04720416. Epub 2016 Dec 9.
4
Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay.基于凝胶过滤法的维持性血液透析患者钙磷颗粒的中期预测价值。
Atherosclerosis. 2020 Jun;303:46-52. doi: 10.1016/j.atherosclerosis.2020.03.016. Epub 2020 Mar 21.
5
High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.高通量血液透析和高容量血液滤过可改善血清钙化倾向。
PLoS One. 2016 Apr 11;11(4):e0151508. doi: 10.1371/journal.pone.0151508. eCollection 2016.
6
Serum Calcification Propensity and Clinical Events in CKD.血清钙化倾向与 CKD 的临床事件。
Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1562-1571. doi: 10.2215/CJN.04710419. Epub 2019 Oct 28.
7
Serum calcification propensity predicts all-cause mortality in predialysis CKD.血清钙化倾向可预测透析前 CKD 的全因死亡率。
J Am Soc Nephrol. 2014 Feb;25(2):339-48. doi: 10.1681/ASN.2013060635. Epub 2013 Oct 31.
8
Serum Calcification Propensity and the Risk of Cardiovascular and All-Cause Mortality in the General Population: The PREVEND Study.人群中血清钙化倾向与心血管和全因死亡率的关系:PREVEND 研究。
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1942-1951. doi: 10.1161/ATVBAHA.120.314187. Epub 2020 Jun 4.
9
The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial.增加透析液镁对终末期肾病患者血清钙化倾向的影响:一项随机对照临床试验。
Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1373-1380. doi: 10.2215/CJN.13921217. Epub 2018 Aug 21.
10
Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.蔗糖铁氧羟化物对透析患者内源性钙磷复合物、炎症和血管细胞的影响。
Nephrol Dial Transplant. 2023 May 4;38(5):1282-1296. doi: 10.1093/ndt/gfac271.

引用本文的文献

1
The true cost of phosphate control in chronic kidney disease.慢性肾脏病中磷酸盐控制的真实成本。
Clin Kidney J. 2025 Mar 13;18(Suppl 1):i46-i60. doi: 10.1093/ckj/sfae434. eCollection 2025 Mar.
2
Elevated phosphate levels in CKD - a direct threat for the heart.慢性肾脏病中升高的磷酸盐水平——对心脏的直接威胁。
Nephrol Dial Transplant. 2025 Jun 30;40(7):1294-1309. doi: 10.1093/ndt/gfaf001.